Sort   by:  
 Page size 
UnknownCost-effectiveness of Anti-CD19 chimeric antigen receptor T-Cell therapy in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. A societal view.
Not available
S-EPMC7497258 | biostudies-literature
UnknownChallenges and controversies in resectable non-small cell lung cancer: a clinician's perspective.
Not available
S-EPMC10928275 | biostudies-literature
UnknownNew systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe.
Not available
S-EPMC10928304 | biostudies-literature
UnknownHospital costs and cosmetic outcome of benign and high-risk breast lesions managed by vacuum-assisted excision versus surgical excision.
Not available
S-EPMC10162056 | biostudies-literature
UnknownHealth Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future.
Not available
S-EPMC8051992 | biostudies-literature
UnknownTreatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
Not available
S-EPMC5754407 | biostudies-literature
UnknownA cost-effectiveness analysis of the effect of hospital variation in the probability of providing treatment with curative intent in potentially curable esophageal and gastric cancer patients.
Not available
S-EPMC12272846 | biostudies-literature
UnknownRegionalization of Hip Fracture Care in Five High-Income Countries.
Not available
S-EPMC12636264 | biostudies-literature
UnknownSelecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial.
Not available
S-EPMC6247672 | biostudies-literature
UnknownComparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients.
Not available
S-EPMC12819094 | biostudies-literature
Sort   by:  
 Page size